Contrast Media Market Trends

Contrast Media Market Trends

• Vendors are increasingly focusing towards developing a new contrast agent with improved imaging agents characteristics, targeting abilities, and biocompatibility profiles. For instance, according to the Radiological Society of North America (RCNA), Gadopiclenol, a new MRI contrast media approved by the FDA in September 2022 uses a lower concentration of gadolinium than existing medias, however, delivers equivalent/improved diagnostic results. Such improvements are driving the adoption of new and advanced contrast media in the market.
   
• Vendors have also recognized an increasing demand for personalized imaging solutions to meet distinct clinical requirements and imaging obstacles. Tailored contrast agents are being created for diverse imaging modalities, clinical applications (such as oncology, cardiology, neurology), and patient cohorts to effectively meet the specific demands of end user.
   
• Significant improvements in packaging of contrast media have introduced innovative packaging options including bulk, multi-dose containers and polymer containers. The use of polymer packaging containers over traditional glass packaging has increased owing to several benefits including reduced storage, improved safety of workplace, and decreased cost of waste disposal.